Browse by People

Antoniou, M ORCID: 0000-0002-0173-1257, Kolamunnage-Dona, R ORCID: 0000-0003-3886-6208 and Jorgensen, AL ORCID: 0000-0002-6977-9337 (2017) Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. Journal of Personalized Medicine, 7 (1). 1-.

Antoniou, M, Kolamunnage-Dona, R ORCID: 0000-0003-3886-6208, Wason, J, Bathia, R, Billingham, C, Bliss, JM, Brown, LC, Gillman, A, Paul, J and Jorgensen, AL ORCID: 0000-0002-6977-9337 (2019) Biomarker-guided trials: Challenges in practice. Contemporary Clinical Trials Communications, 16. p. 100493.

Collapse authors list.
Carr, DF, Chaponda, M, Cornejo Castro, EM, Jorgensen, AL ORCID: 0000-0002-6977-9337, Khoo, S ORCID: 0000-0002-2769-0967, Van Oosterhout, JJ, Dandara, C, Kampira, E, Ssali, F, Munderi, P et al (show 3 more authors) , Lalloo, DG ORCID: 0000-0001-7680-2200, Heyderman, RS and Pirmohamed, M ORCID: 0000-0002-7534-7266 (2014) CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations. Journal of Antimicrobial Chemotherapy, 69 (12). pp. 3329-3334.

Smith, EMD, Yin, P, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Beresford, MW ORCID: 0000-0002-5400-9911 (2018) Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. LUPUS, 27 (13). pp. 2020-2028.

Smith, EMD, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Beresford, MW ORCID: 0000-0002-5400-9911 (2017) Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study. Lupus, 26 (11). pp. 1212-1217.

Smith, EMD, Lewandowski, LB, Jorgensen, AL ORCID: 0000-0002-6977-9337, Phuti, A, Nourse, P, Scott, C and Beresford, MW ORCID: 0000-0002-5400-9911 (2018) Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort. LUPUS, 27 (14). pp. 2190-2199.

Collapse authors list.
Smith, EMD, Jorgensen, AL ORCID: 0000-0002-6977-9337, Midgley, A, Oni, L ORCID: 0000-0002-1532-2390, Goilav, B, Putterman, C, Wahezi, D, Rubinstein, T, Ekdawy, D, Corkhill, R et al (show 6 more authors) , Jones, CA, Marks, SD, Newland, P, Pilkington, C, Tullus, K and Beresford, MW ORCID: 0000-0002-5400-9911 (2017) International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Pediatric Nephrology, 32 (2). pp. 283-295.

Turner, RM ORCID: 0000-0002-7315-679X, Yin, P, Hanson, A, FitzGerald, R, Morris, AP, Stables, RH ORCID: 0000-0002-9244-7015, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Pirmohamed, M ORCID: 0000-0002-7534-7266 (2017) Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome. Journal of Clinical Lipidology, 11 (1). pp. 204-214.

Collapse authors list.
Herrera Luis, E, Ortega, VE, Ampleford, EJ, Sio, YY, Granell, R, De Roos, E, Terzikhan, N, Vergara, E Elorduy, Hernandez-Pacheco, N, Perez-Garcia, J et al (show 53 more authors) , Martin-Gonzalez, E, Lorenzo-Diaz, F, Hashimoto, S, Brinkman, P, Jorgensen, AL ORCID: 0000-0002-6977-9337, Yan, Q, Forno, E, Vijverberg, SJ, Lethem, R, Espuela-Ortiz, A, Gorenjak, M, Eng, C, Gonzalez-Perez, R, Hernandez-Perez, JM, Poza-Guedes, P, Sardon, O, Corcuera, P, Hawkins, GA, Marsico, A, Bahmer, T, Rabe, KF, Hansen, G, Kopp, MV, Rios, R, Cruz, MJ, Gonzalez-Barcala, F, Olaguibel, JM, Plaza, V, Quirce, S, Canino, G, Cloutier, M, Del Pozo, V, Rodriguez-Santana, JR, Korta-Murua, J, Villar, J, Potocnik, U, Figueiredo, C, Kabesch, M, Mukhopadhyay, S, Pirmohamed, M, Hawcutt, DB ORCID: 0000-0002-8120-6507, Melen, E, Palmer, CN, Turner, S, Maitland-Van der Zee, AH, Von Mutius, E, Celeclon, JC, Brusselle, G, Chew, FT, Bleecker, E, Meyers, D, Burchard, EG and Pino-Yanes, M (2022) Multi-ancestral meta-analysis yields novel genetic loci for asthma exacerbations. In: ERS International Congress 2022 abstracts.

Richardson, M ORCID: 0000-0002-7097-8704, Kirkham, J ORCID: 0000-0003-2579-9325, Dwan, K, Sloan, DJ, Davies, G ORCID: 0000-0002-3819-490X and Jorgensen, AL ORCID: 0000-0002-6977-9337 (2019) NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 23 (3). pp. 293-305.

McWilliam, SJ ORCID: 0000-0002-0509-7425, Antoine, DJ, Sabbisetti, VS, Pearce, RE, Jorgensen, AL ORCID: 0000-0002-6977-9337, Lin, Y, Leeder, JS, Bonventre, JV, Smyth, RL and Pirmohamed, M ORCID: 0000-0002-7534-7266 (2014) Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomarkers in Medicine, 8 (10). pp. 1189-1197.

Carr, DF, Wang, C-W, Bellon, T, Ressel, L ORCID: 0000-0002-6614-1223, Nwikue, G, Shrivastava, V, Bergfeld, W, Jorgensen, AL ORCID: 0000-0002-6977-9337, Chung, W-H and Pirmohamed, M ORCID: 0000-0002-7534-7266 (2019) Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. BRITISH JOURNAL OF DERMATOLOGY, 181 (1). pp. 166-174.

Syed, H, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Morris, AP (2017) SurvivalGWAS_SV: software for the analysis of genome-wide association studies of imputed genotypes with "time-to-event" outcomes. BMC bioinformatics, 18 (1). 265-.

Collapse authors list.
Hawcutt, DB ORCID: 0000-0002-8120-6507, Francis, B ORCID: 0000-0002-2130-5976, Carr, D, Jorgensen, AL ORCID: 0000-0002-6977-9337, Yin, P, Wallin, N, O'Hara, NJ, Zhang, JE ORCID: 0000-0003-1813-2207, Bloch, KM, Ganguli, A et al (show 9 more authors) , Thompson, B, McEvoy, LR ORCID: 0000-0002-2169-6735, Peak, M ORCID: 0000-0003-1909-3211, Crawford, AA, Walker, BR, Blair, CB, Couriel, J, Smyth, RL and Pirmohamed, M ORCID: 0000-0002-7534-7266 (2018) Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. The Lancet Respiratory Medicine, 6 (6). pp. 442-450.

Cliff, JR, Carr, DF, Lord, RH, Jorgensen, AL ORCID: 0000-0002-6977-9337 and Pirmohamed, M ORCID: 0000-0002-7534-7266 (2016) A candidate gene study for oxaliplatin induced chronic peripheral neuropathy (OICPN) based on a prior genome wide association study (GWAS). .